Introduction
Members of the genus Acinetobacter are ubiquitous, free living organisms that prefer moist environment and can be easily obtained from soil, water, food and sewage [1] . They are usually considered to be opportunistic pathogens, and of recent have been reported to cause a number of outbreaks of nosocomial infections in hospitalized patients like septicaemia, pneumonia, wound sepsis, endocarditis, meningitis and urinary tract infection (UTI) [2, 3] . Although acknowledged to be an opportunist in hospitalised patients, community acquired infections are reported and they can cause infections in virtually every organ system [4] . Interpreting the significance of isolates from clinical specimens is often difficult, because of the wide distribution of Acinetobacter in nature and its ability to colonise healthy or damaged tissue [5] . This study was undertaken to determine the prevalence, and antibiotic resistance pattern of Acinetobacter species from various clinical samples.
II. Material And Method
The study was undertaken in Department of Microbiology, P.D.U. Medical College, Rajkot (Gujarat, India), from period November 2012 to August 2014. Total 1000 clinical samples received in our laboratory from patients treated at P.D.U. Hospital Rajkot were included in this study. All the clinical samples were inoculated on MacConkey agar and blood agar. Inoculated plates were incubated at 37°C for 24 -48 hours. Colonies of Acinetobacter species were white/cream coloured, smooth, circular with entire edges on blood agar and nonfermenter with a pinkish tint on MacConkey agar. Microscopy showed gram negative coccobacilli on gram stain. Oxidase test was negative [6, 7] . 
III. Result
Total 1000 patients clinical samples were included in present study, out of which 48(4.8%) showed growth of Acinetobacter species.
Acinetobacter species were isolated highest from blood 24 (50%), followed by pus 15 (31.25%), urine 4 (8.33%), CSF 2 (4.18%), sputum 1 (2.08%), plural fluid 1 (2.08%) and tracheal aspirate 1 (2.08%) ( Table 1) . Number of Acinetobacter species were more from paediatric ward followed by surgical ward. Most of the isolates from paediatric ward was from preterm babies ( Table 2 ). 
IV. Discussion
Acinetobacter spp. are the second most common Non-fermenting bacteria after Pseudomonas species that are isolated from human specimens, especially among nosocomial infections. [10] In recent years, this species has emerged as the causative agent of important nosocomial infections in the ICUs, which is probably related to the increasingly invasive procedures used, the greater quantity of broad-spectrum antimicrobials used, and prolonged duration of stay in the hospital. Development of resistance to antimicrobials is a major problem in the treatment of Acinetobacter infections. [11] Isolation rate of Acinetobacter species in present study was 4.8%, which is quite comparable with Lone et al (4.8%) [12] and Mindolli PB et al(4.25%) [13] . Higher prevalence rates of 14% and 9.6% among hospital isolates were observed by Mostofi et al. ( Iran) and Joshi et al. (India), respectively [14, 15] . Acinetobacter spp. can colonize skin, wounds, respiratory and gastrointestinal tracts. [16] It is a pathogen of tropical and humid environment, but some species can survive environmental desiccation for weeks, a characteristic that promotes transmission through fomite contamination in hospitals. [17] In present study Acinetobacter species were isolated highest from blood 24 (50%), followed by pus 15 (31.25%), urine 4 (8.33%), CSF 2 (4.18%), sputum 1 (2.08%), plural fluid 1 (2.08%) and tracheal aspirate 1 (2.08%). Highest isolation was from blood, most of them were from preterm babies, where due to lower immunity, more chances of bacterial infection. In a study conducted by A. Asensio et al in 2008 Acinetobacter was isolated from respiratory tract (42.2%), surgical wound (15.1%), urinary tract (12.9%), skin (11.7%) [18] .
In our study, 20.83% isolates were MDR & 20.83% isolates were XDR. The other studies conducted by Bhattacharyya et al. in West Bengal [19] and Mostofi et al. in Tehran[14] reported the MDR isolates to be 29% and 54%, respectively. Acinetobacter is ubiquitous in the hospital setting. Its ability to survive for long periods coupled with its ability to demonstrate a number of antimicrobial resistance genes has made Acinetobacter a successful hospital pathogen. [20, 21] Most of the patients who were admitted in our hospital had previously attended primary and secondary care hospitals and usually received combination of β-lactam antibiotics like third and fourth generation Cephalosporins along with Aminoglycosides or Fluoroquinolones. Majority of the isolates in our study were resistant to commonly used antibiotics such as Ceftazidime(79.17%), Cefepime(87.5%), Gentamicin(62.5%), Amikacin(52.09%), Levofloxacin(68.75%), and Ampicillin/sulbactam(64.58%). This suggest that MDR isolates are increasing, probably due to indiscriminate use of these antibiotics in healthcare settings. It is reemphasized that broad spectrum antibiotics should be used with caution. We found that, Meropenem(41.67%) and Piperacillin/Tazobactam(58.34%) were also showing resistance against this pathogen suggesting increased [14] . Differences observed between the different studies, could be due to the methods, the resistance patterns and and the antimicrobial patterns used [22] . Although antibiotic resistance is a worldwide concern, it is first and foremost a local problem -selection for and amplification of resistant members of a species that are occurring in individual hospitals and communities, which can then spread worldwide [23] There are many measures that may impact on antimicrobial resistance; reducing and restricting the use of antimicrobials to only those situations where they are warranted, at proper dose and for the proper duration is the most appropriate solution. [24] Carbapenems have been the drug of choice for treating Acinetobacter infections, but unfortunately, Carbapenem resistant Acinetobacter is becoming common worldwide [25, 26] 
V. Conclusion
In the present study Acinetobacter spp. accounted for 4.8% of total culture. Resistance observed to Meropenem was 41.67%, Piperacillin -Tazobactam 58.34%, Amikacin 52.09%, Ceftazidime 79.17%, Gentamicin 62.5%, Levoflaxacin 68.75% which suggested that Acinetobacter isolated from hospital exhibit resistance to multiple antimicrobial drugs. Traditional typing methods like phenotyping and antibiogram typing have an advantage over genotyping as they are readily available in all clinical microbiology laboratories. Simple identification schemes and antimicrobial susceptibility testing provide a cost effective approach for typing Acinetobacter spp. Although above systems have certain limitations when compared to molecular methodologies, the distinction between resistant and susceptible Acinetobacters atleast, is useful for effective clinical management of the infection caused by this group of organisms. Overall infections caused by Acinetobacter spp. Provide an impressive demonstration of the increasing importance of this genus as human pathogen because of the high potential of this genus to develop antibiotic resistance leading to a considerable selective advantage in environment with widespread and heavy use of antibiotic, especially with relation to hospital environment and nosocomial infections. To avoid resistance, antibiotics should be used judiciously and empirical antibiotic therapy should be determined based on local antibiotic sensitivity pattern of the prevalent organisms of the hospital.
